Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01642823 · ClinicalTrials.gov registry record
Cancer Biology of Retinoblastoma
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 8
- Enrollment target
NCT01642823: Clinical Trial study, sponsored by Stanford University.
NCT01642823 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01642823 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Many children with the childhood cancer, Retinoblastoma, have surgery to remove the tumor and sometimes the entire eye. The purpose of this study is to collect the extra tissue from patients who undergo tumor removal for laboratory experiments that will help us understand not only what occurs in retinoblastoma cells but also how cells normally function. Some of these studies will include an evaluation of how cells control the way that genes are expressed, how cells "know" to become retinal cells, how cells remain retinal cells, how cells lose their identity as retinal cells, what changes make retinoblastoma cells different from normal retinal cells, and what changes make some retinoblastomas worse than others.
Primary Outcome
Comparison of number of reprogramming events (defined by colony formation assay and normalized for number of cell plated) as well as the time to reprogramming.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-12 |
Why NCT01642823 stopped before completion
NCT01642823 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01642823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01642823 about?
NCT01642823 is a clinical study titled "Cancer Biology of Retinoblastoma". Many children with the childhood cancer, Retinoblastoma, have surgery to remove the tumor and sometimes the entire eye. The purpose of this study is to collect the extra tissue from patients who undergo tumor removal for laboratory experiments that will help us understand not only what occurs in ret...
What is the current status of trial NCT01642823?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2012-07. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01642823?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia